| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $5.85B | $5.13B | $4.44B | $3.59B | $2.91B |
| SG&A | $2.70B | $2.95B | $2.63B | $2.12B | $1.82B |
| Operating Income | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B |
| Interest Expense | – | – | $73.00M | $59.40M | $57.30M |
| Tax Expense | $725.80M | $367.30M | $245.70M | $520.40M | $1.25B |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B |
| EPS (basic) | 43.0700 | 40.9000 | 37.0500 | 40.5100 | 76.4000 |
| EPS (diluted) | 41.4800 | 38.3400 | 34.7700 | 38.2200 | 71.9700 |
| Shares (diluted) | $108.60M | $115.10M | $113.70M | $113.50M | $112.20M |